New PET scan could spot hidden diseases early
NCT ID NCT07400224
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new imaging method called Al18F-NOTA-FAPI-04 PET/CT or PET/MRI to see if it can better detect and guide treatment for malignant tumors, heart problems, and autoimmune diseases like hyperthyroidism. About 600 adults will receive the imaging agent and be monitored for safety and accuracy. The goal is to improve diagnosis and treatment planning without providing a direct cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR ABNORMALITIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shield for bone marrow: can a drug stop Chemo's blood cell side effect?
- New imaging agent could sharpen cancer detection
- New drug cocktail aims to stop Chemo-Linked nausea before it starts
- Could a painless electrical patch help cancer patients sleep better after surgery?
- Your tongue could reveal cancer: AI study analyzes 4,100 people
- New study aims to predict immunotherapy success in cancer patients